Business
IDGLOBAL Announces 10 Year Contract with Major Pharmaceutical Label Manufacturer
IDGLOBAL Announces 10 Year Contract with Major Pharmaceutical Label Manufacturer.
About this update from Idglobal Corp.
[{"type":"text","content":"KELOWNA, British Columbia--July 24th,2007 (BUSINESS WIRE)--IDGLOBAL (Pink Sheets:IDGJ - News) is pleased to announce to its shareholders that IDGLOBAL has secured an unprecedented ten (10) year contract to supply its' Nano-Molecular Marking?, anti-counterfeiting technology, to the renowned pharmaceutical labeling corporation ATL Pharma Security Label Systems? (www.atlco.com), a division of Ad Tape & Label Co. This 10 year supply contract guarantees ATL the ability to incorporate IDGlobal's Nano-Molecular Marking? technologies into any of ATL's Pharmaceutical labeling solutions to provide its clients the highest level of protection against counterfeited labels. \n\nATL is one of the world's leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in \"private brand\" disposable medical device manufacturing. See attached link Pharmaceutical Counterfeiting for more information:\nhttp://www.atlco.com/medical/PharmaAntiCounterfeiting.html\n\nCounterfeit drugs pose significant public health and safety concerns. They may contain only inactive ingredients, incorrect ingredients, improper dosages, sub-potent or super-potent ingredients, or be contaminated. As a result, patients may be put at risk for serious adverse health consequences. For example, Procrit, a drug used by cancer and AIDS patients, was recently counterfeited and the drug was replaced with nonsterile tap water, which could have caused a severe infection of the bloodstream. In another recent counterfeiting incident, white tablets with \"aspirin\" imprinted on them replaced Zyprexa, a drug used for schizophrenia and acute bipolar disorder. This could have been particularly dangerous for patients who are aspirin-sensitive or aspirin-allergic or who have bleeding disorders. In addition, patients no longer received appropriate treatment for their illness. Counterfeiters also have been known to switch lower-strength drug(s) for higher strength drug(s). As a result, patients receive lower than expected doses of dr...